The Rapid program is a collaborative, international quality improvement program studying the prospective use of medications and non-pharmacological interventions commonly used in palliative care and cancer symptom management.
The program includes multi-site, consecutive-cohort, post-marketing series that examine interventions to collate data on widespread and longer-term use of medications and non-pharmacological interventions.
The program is called Rapid because it involves:
- Rapid data collection
- Rapid collation and analysis
- Rapid reporting
- Rapid influence on clinical practice
We aim to collect information about interventions commonly used in palliative care and cancer symptom management including:
- the therapeutic benefit of medications and non-pharmacological interventions
- the net clinical response (harms and benefits) of medications and non-pharmacological interventions
- any significant drug/drug, drug/host interactions of medications and non-pharmacological interventions.
We achieve our aims by:
- engaging with palliative care and cancer services around the globe to increase participation in the program
- providing central coordination and support to participating sites through the IMPACCT Trials Coordination Centre
- actively seeking input from participants to nominate new series for investigation.
The Rapid program is successful because it:
- uses minimal resources
- is timely
- involves clinicians from around the globe
- publishes each series to improve the knowledge base for clinical prescribing and use of non-pharmacological therapies
- focuses on interventions that are commonplace in palliative care and cancer practice.
- to evaluate the benefit and toxicity of medications and other interventions being used in palliative care and cancer symptom management
- to describe the indications for medications and other interventions being used in palliative care and cancer symptom management
- to document the frequency of prescribing of common medications and other interventions in this setting.
Who can participate?
Clinicians working with a palliative or cancer population at a location in Australia or overseas
If you participate, you will:
- be collaborating with two investigator initiated clinical trials collaboratives, Palliative Care Clinical Studies Collaborative (PaCCSC) and Cancer Symptom Trials (CST)
- develop the capacity and research capabilities of you and/or your staff who may not otherwise have the opportunity to engage in research
- be contributing to the evidence base to support clinical decision making in palliative care and cancer symptom management
- become a member of PaCCSC or CST, or both - you choose which collaborative/s to join
- receive support and central coordination from the IMPACCT Trials Coordination Centre (ITCC)
Questions? Send your enquiry to Rapid@uts.edu.au
Put your site on the map!
RAPID is truly an international collaboration. Participating sites are indicated on the map below. Find out how to get involved.